[Effect of caffeine on myocardial blood flow during pharmacological vasodilation]

J P Wielepp1, E Fricke, D Horstkotte

  • 1Institut für Molekulare Biophysik, Radiopharmazie und Nuklearmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Ruhr-Universität Bochum, Georgstr. 11, 32545, Bad Oeynhausen, Germany. pwielepp@hdz-nrw.de

Zeitschrift Fur Kardiologie
|January 28, 2005
PubMed

Insights

Caffeine intake significantly reduces myocardial blood flow during adenosine stress tests, potentially lowering diagnostic accuracy for coronary artery disease. Patients should avoid caffeine before this cardiac imaging procedure.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Pharmacology

Background:

  • Pharmacologic stress testing with adenosine is a key method for diagnosing coronary artery disease (CAD).
  • Caffeine, a common dietary component, may interfere with adenosine's vasodilatory effects, impacting test results.

Observation:

  • A case study examined myocardial blood flow in a patient with CAD using ammonia positron emission tomography (PET).
  • Measurements were taken during adenosine-induced hyperemia, both after consuming decaffeinated coffee and without caffeine intake.

Findings:

  • Caffeine intake resulted in a diminished increase in myocardial blood flow during adenosine stress.
  • Coronary flow reserve decreased from 2.3 (without caffeine) to 1.3 (after caffeine intake).
  • This indicates caffeine alters the coronary vasodilatory capacity.

Implications:

  • Careful patient screening for caffeine consumption is crucial before adenosine stress testing.
  • Reduced coronary flow reserve due to caffeine may compromise the diagnostic sensitivity of noninvasive CAD detection.
  • Findings highlight the need to optimize pre-test protocols for accurate cardiac assessment.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...